Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Biochips in bladder cancer research].

J Suhr1, A Eisenhardt, K W Schmid

  • 1Nationales Genomforschungsnetzwerk, Urologische Klinik and Institut für Pathologie, Universität Essen.

Der Urologe. Ausg. A
|August 5, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fibroblast activation protein-α expression in fibroblasts is common in the tumor microenvironment of colorectal cancer and may serve as a therapeutic target.

Pathology oncology research : POR·2023
Same author

A prognostic systemic inflammation score (SIS) in patients with advanced intrahepatic cholangiocarcinoma.

Journal of cancer research and clinical oncology·2022
Same author

[Hemithyroidectomy or total thyroidectomy for low-risk papillary thyroid cancer? : Surgical criteria for primary and secondary choice of treatment in an interdisciplinary treatment concept].

Chirurgie (Heidelberg, Germany)·2022
Same author

Multimodal survival prediction in advanced pancreatic cancer using machine learning.

ESMO open·2022
Same author

[Are there benefits for catheter valves for catheter-associated quality of life? : Results of an investigation in 427 catheter wearers with life-long indication].

Urologie (Heidelberg, Germany)·2022
Same author

[Quality of life for wearers of a suprapubic or transurethral bladder catheter as lifelong permanent care].

Der Urologe. Ausg. A·2021

Combining DNA, protein, and tissue microarrays may detect bladder cancer genes. Surface-enhanced laser desorption/ionization (SELDI) technology can confirm protein relevance for cancer progression and new therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biotechnology

Background:

  • Bladder cancer progression involves complex genetic and protein alterations.
  • Current diagnostic and prognostic tools have limitations in capturing the full biological picture.

Purpose of the Study:

  • To explore the combined potential of DNA, protein, and tissue microarrays for bladder cancer detection.
  • To investigate the role of SELDI technology in validating gene-protein correlations in bladder cancer.
  • To facilitate the development of novel prognostic markers and therapeutic strategies for bladder cancer.

Main Methods:

  • Utilizing DNA microarrays for gene identification specific to bladder cancer.
  • Employing protein arrays and SELDI technology to confirm gene translation into proteins.

Related Experiment Videos

  • Applying tissue microarrays for validation of potential prognostic markers in large populations.

    • Main Results:

    • The synergistic application of these microarray techniques offers a promising approach for bladder cancer biomarker discovery.
    • SELDI technology can effectively bridge the gap between genetic findings and their functional protein implications.
    • Tissue microarrays provide a scalable platform for validating potential bladder cancer markers.

    Conclusions:

    • Integrated omics approaches, including DNA, protein, and tissue microarrays, are crucial for advancing bladder cancer research.
    • The combination of these technologies holds significant potential for identifying novel prognostic markers and therapeutic targets.
    • Future research should focus on translating these findings into clinical applications for personalized bladder cancer treatment.